drugset / Trial / NCT00590915
Erwinase Master Treatment Protocol
Expanded access
No longer available
Phoenix Children's Hospital
Fisher Bioservices · collabJazz Pharmaceuticals · collab
Summary
The purpose of this study is to make Erwinase available to patients with acute lymphoblastic leukemia (ALL) who have had previous allergic reactions to certain formulations of L-asparaginase.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Asparaginase Erwinia chrysanthemi | Protein / enzyme biologic | 25000 unknown | Intramuscular |